Table 1.
No & type of treatment | Concentration of treatment & No of ova | No and % of cleavage rate | Degenerating ova no & % | Total cleavage % | Total Blastula stage | Total degenerating |
---|---|---|---|---|---|---|
Scripted SCR 179 ova |
5 nM = 64 ova | 11 = 17.18% | 53 = 82.82% | 41/179 = 22.91% | 3/41 = 7.31%* | 138/179 77.09% |
50 nM = 73 ova | 14 = 19.17% | 59 = 80.82% | ||||
500 nM = 42 ova | 16 = 38.09%* | 26 = 61.91% | ||||
Trichostatin (A) TSA 134 ova |
5 nM = 53 ova | 12 = 22.64% | 41 = 77.36% | 35/134 = 28.69% | 0/35 = 0% | 87/134 = 71.31% |
50 nM = 43 ova | 8 = 18.6% | 35 = 81.4% | ||||
500 nM = 38 ova | 15 = 39.47%* | 23 = 60.53% | ||||
Control 275 ova | 0 nM = 94 ova | 29 = 30.85%* | 65 = 69.15% | 89/275 = 32.36% | 4/89 = 4.49%* | 186/275 = 67.64% |
0 nM = 90 ova | 27 = 30.%* | 63 = 70.0% | ||||
0 nM = 91 ova | 25 = 27.47%* | 66 = 72.53% |
(*) Significantly difference at p < 0.05 compared to the others without star at the same type of treatment or columens.